VEEV Add to watchlist $193.09 3.72 (-1.89%) Last updated: Jul 15, 2026 04:33
52-Week Range
$193.09
$148.05 $193.09 $310.50

Fundamentals Overview

Veeva Systems Inc. is in the middle of its 52-week range with premium valuation, trading relatively flat today.

Valuation premium

P/E 34 PEG 1.65 P/B 4.32 P/S 9.45

Intrinsic value (DCF)

-25.6% downside vs price

Profitability

Net margin 28.4%

Risk (Beta)

0.94 — in line vol

Earnings & growth

EPS $5.67 Rev +5.6% Profit +6.9% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell
Buy
Hold — 55% confidence Risk: Moderate Volatility — Beta 0.94. Diversify and only invest what you can afford to lose.

Supporting (Buy):

Analyst grade: A- · 3M vs S&P 500: +12.3% · 3M vs Healthcare sector: +14.9%

Pressures (Sell):

DCF 25.6% downside vs price · Sentiment weakening (1 downgrade)

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap
$31.37B
P/E (TTM)
34.04
EPS (TTM)
$5.67
Dividend Yield
N/A
52-Week Range
$148.05 - $310.50
Volume vs Avg
N/A
Beta
0.94

About

Veeva Systems Inc. is a leading provider of cloud-based software solutions, exclusively dedicated to the global life sciences industry. Its extensive operational presence spans across North America, Europe, the Asia Pacific region, the Middle East, Africa, and Latin America. The company's product portfolio is primarily structured around two major offerings. First, the Veeva Commercial Cloud delivers an integrated suite of software, data, and analytics tools designed to optimize commercial operat...
Sector: Healthcare
Headquarters: US
Employees: 7,928
IPO Date: Oct 2013
Website: www.veeva.com
Beta: 0.94 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: A-. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 8, Equal Weight: 1, Hold: 2, In Line: 2, Market Perform: 1, Neutral: 4, Outperform: 6, Overweight: 5, Sell: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $143.64; current price is $193.09. That’s a -25.6% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric Value
Valuation
P/E (TTM) 34.04
DCF value (model) $143.64 (-25.6% vs price)
PEG (TTM) 1.65
P/B (TTM) 4.32
P/S (TTM) 9.45
P/FCF (TTM) 19.08
Liquidity & enterprise
Current Ratio (TTM) 4.74
Quick Ratio (TTM) 4.74
Cash Ratio (TTM) 1.11
Profitability
ROE (TTM) N/A
ROA (TTM) N/A
Revenue growth (YoY) N/A
Net margin (TTM) 28.37%
Gross margin (TTM) 74.95%
Operating margin (TTM) 28.79%
Debt to equity (TTM) N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for VEEV.

Analyst Sentiment at a Glance

A- Sentiment Weakening
Buy 8Equal Weight 1Hold 2In Line 2Market Perform 1Neutral 4Outperform 6Overweight 5Sell 1
0 upgrades, 1 downgrade
Price Target Consensus
Current $193.09
Median $230.00
Consensus $235.38
Low consensus $165.00
High consensus $320.00

Stock Grades (Institutions)

Institution Action Previous Grade New Grade Date
Mizuho maintain Outperform Outperform 2026-06-04
UBS maintain Neutral Neutral 2026-06-04
Evercore ISI Group maintain In Line In Line 2026-06-04
Oppenheimer maintain Outperform Outperform 2026-06-04
Citigroup maintain Neutral Neutral 2026-06-04
BMO Capital maintain Market Perform Market Perform 2026-06-04
Canaccord Genuity maintain Hold Hold 2026-06-04
Goldman Sachs maintain Sell Sell 2026-06-04
Barclays maintain Overweight Overweight 2026-06-04
Baird maintain Outperform Outperform 2026-06-04
Piper Sandler maintain Overweight Overweight 2026-06-04
Needham maintain Buy Buy 2026-06-04
Stifel maintain Buy Buy 2026-06-04
BTIG maintain Buy Buy 2026-06-04
Wells Fargo maintain Overweight Overweight 2026-06-04
RBC Capital maintain Outperform Outperform 2026-06-04
Oppenheimer maintain Outperform Outperform 2026-05-18
Citigroup downgrade Buy Neutral 2026-04-10
Citigroup maintain Buy Buy 2026-03-09
Needham maintain Buy Buy 2026-03-05
Canaccord Genuity maintain Hold Hold 2026-03-05
Wells Fargo maintain Overweight Overweight 2026-03-05
Piper Sandler maintain Overweight Overweight 2026-03-05
Truist Securities maintain Buy Buy 2026-03-05
Stifel maintain Buy Buy 2026-03-05
RBC Capital maintain Outperform Outperform 2026-03-05
UBS maintain Neutral Neutral 2026-03-05
TD Cowen maintain Buy Buy 2026-03-05
Evercore ISI Group maintain In Line In Line 2026-03-05
Morgan Stanley maintain Equal Weight Equal Weight 2026-03-05